Cryoport Systems is transforming the advanced therapies supply chain with integrated services that support every stage of ...

Sterling will manufacture cGMP clinical material for KIVU-107 at its bioconjugation facility in Deeside, UK. Kivu Bioscience, ...

PharmaLogic Holdings Corp., a CDMO specialized in radiopharmaceuticals, has appointed Etienne Montagut, currently serving as ...

Aims to advance cutaneous drug delivery into the skin for Epidermolysis Bullosa. DEBRA Research GmbH, a global non-profit ...

Sanofi has entered into an agreement to acquire Blueprint Medicines Corp., a U.S.-based biopharma company specializing in ...

The CDMO's head of development talks about ADCs, accelerated timelines, and the push for end-to-end development services.

HHS previously awarded $176 million for a mRNA-based vaccine against the H5N1 avian influenza. Moderna, Inc. received notice ...

Astellas gains worldwide rights to develop XNW2701 being evaluated in solid tumors, including gastric, gastroesophageal and ...

LyoWave has also received a $50,000 Phase I grant from the Indiana Economic Development Corp.’s Applied Research Institute.

Bora Pharmaceuticals Co. Ltd. has announced plans to add further sterile fill/finish capacity at its facility in Baltimore, ...

In today’s high-stakes pharma environment, where supply chain risks, rising tariffs, and time-to-market pressures dominate, ...

Bionique Testing Laboratories and Cellipont Bioservices have partnered to advance the adoption and validation of rapid ...